The on-off regulation of drug release offers an effective strategy for self-regulated insulin delivery in response to glucose, and the repeated on-demand drug delivery restricts the clinical application of glucose-sensitive carriers for therapy of diabetes (Figure 3d) [66]. This evidence concerns the gene INS and diabetes mellitus.